Developers of current and next generation biopharmaceuticals are challenged to provide increasingly deeper characterization of inherently more complex molecules. Driven by the power of the Zeno trap coupled with electron activated dissociation (EAD) fragmentation technology, the ZenoTOF 7600 system unlocks sensitivity gains allowing you to uncover new information for certainty in your results to make better-informed decisions, faster.

Detect up to 20x more ions in every experiment and access a spectrum of tuneable fragmentation techniques to unlock new perspectives for every molecule, in every experiment. Reach a new level of confidence and insight for the characterization of your most challenging biotherapeutics

Discover how you can:

• Dramatically increase fragment ion coverage for better peptide maps that include low abundance, labile PTMs
• Quickly and accurately produce intact and subunit results, that you can be confident in
• Achieve base-specific localization and identification of a wide variety of PTMs across all charge states
• Obtain highly descriptive ion information from Zeno CID and highly accurate positional confirmation with EAD for glycosylation analysis
• Enable complete confirmation of expected disulfides and elucidation of scrambled disulfides